Treatment satisfaction with disease-modifying therapy is the only predictor of Adherence among multiple sclerosis patients from Upper Egypt

Abstract Despite the proven efficacy of the disease-modifying therapy (DMT) for multiple sclerosis (MS), the rates of non-adherence are frequently high. We aimed to evaluate the rate of non-adherence to the first DMT in Upper Egypt and identify different contributing factors. Out of 310 patients, ni...

Full description

Bibliographic Details

Published in:	Scientific Reports
Main Authors:	Eman M. Khedr, Doaa M. Mahmoud, Hussein B. Hussein, Islam E. L. Malky, Sarah S. Mostafa, Ayman Gamea
Format:	Article
Language:	English
Published:	Nature Portfolio 2024-03-01
Subjects:	Multiple sclerosis Disease-modifying treatment Non-adherence Treatment satisfaction Depression Fatigue
Online Access:	https://doi.org/10.1038/s41598-024-57116-9